Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
General Rheumatology
•
Allergy & Immunology
•
Primary Immunodeficiency
Is there any value to IgG subclasses in assessing immune deficiency in a patient with normal IgG levels?
Related Questions
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
How would you approach diagnosis of a patient with recurrent episodes of abdominal pain, severe myalgias, low grade fevers and urticaria?
Are there specific conventional DMARDs and/or biologics that are contraindicated in patients with alpha-gal allergy?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
Is it better to give dose 2 of the mRNA 2024-2025 Covid-19 vaccine at month 2 or month 6 after dose 1 in moderately immunocompromised patients?
When screening for malignancy, do you order CT with contrast (or) both with and without contrast?
How do you approach a patient with idiopathic anterior uveitis who has ongoing disease despite adalimumab every two weeks?
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?
Do you pursue coronary artery calcium scoring in patients with metabolic risk factors and autoimmune disease in order to guide decisions regarding GLP-1 medications?
